2024-02-17
ImmuneOnco (01541.HK) included in the Hang Seng Composite Index
On February 17, 2024, ImmuneOnco Biopharmaceuticals (Shanghai) Inc. (referred to as "ImmuneOnco", Hong Kong Stock Exchange stock code: 01541.HK) announced that, according to the latest quarterly index series released by Hang Seng Indexes Co., Ltd., ImmuneOnco was included in the Hang Seng Composite Index constituent stocks, which will officially take effect on March 4 (Monday) this year.
View more